Buy Sell HICKS THERMOMETERS (INDIA) LIMITED Unlisted shares

Hicks Thermometers (India) Limited

Hicks Thermometers India Limited logo

About the Company

(i) HICKS is the household name in India for 100 years in the field of Thermometers. HICKS was founded by Late Shri V P Gupta, in 1962, with British collaboration. It is an ISO 9001:2008 certified company.

(ii) Today, it has a diversified portfolio of 50 medical instruments such as medical disposables, consumables, diagnostic and pharma range of products.

a) Thermometer

b) Monitoring
Electronic B.P Meter, Digital Weighing Scale, & Fingertips oximeter/Stethoscope.

c) Rehabilitation
Lumbo Scaral Belt & Cirvical Collar, Pouch Arm, Knee-Cap, & Abdominal Belt, etc.

d) Home Health

HICKS Hot water bottle, Hot Water Bags, ICE Burg, Nebulizer, Pregnancy Test Card, Breast Pump, Adult Diaper, etc.

e) Medical

Plaster of Paris, Face Mask, Disposable Surgical blade, Surgeon Cap, etc,

All the above products are sell-through 3000 dealers across the remotest part of India. The company has a dedicated sales team to market its product.

Infrastructure

The manufacturing unit is located at Aligarh, a widely known industrial place situated in U.P., India. The primary advantage is the location that is a well-known industrial estate – just 135 km from New Delhi. The production unit is spread over an area of 7000 square yards. The production section is equipped with high-end manufacturing facilities and the ultra-clean environment – mandatory for the production of a thermometer and Medical Disposable.

Distribution Network

They have a wide marketing network of over 1500 distributors in various states of India. Moreover, they have distribution offices at Delhi, Kolkata, Patna, Jaipur, Nagpur, Mumbai, Guwahati and Chennai along with a marketing team to provide these products to various outlets regularly. This excellent marketing facility also enables them to furnish the bulk amount of products effectively and timely.

Clientele

They have a very strong client base which is well known in this industry. It is an efficient working approach and high customer satisfaction that provides Hicks a rich dividend in terms of a vast global clientele. Several renowned institutions have vested their interests in us. These institutions are :

(i) Apollo Hospitals
(ii) Escort Hospital
(iii) Cadila Pharmaceutical
(iv) Ranbaxy Laboratories
(v) Dr. Reddy’s Laboratories
(vi) Glaxo and many more.

Hicks Thermometers India Limited Unlisted Shares Details:

Total Available Shares:	Not Available
Face Value:	₹ 10 Per Equity Share

Financials of Hicks Thermometers India Limited Unlisted Shares:

Particulars(Cr)	2019	2018	2017
Revenues from operations	53.47	52.89	52.05
EBITDA	4.01	3.47	2.92
PAT	1.89	1.53	1.54
Equity	0.32	0.32	0.32
Face Value	10	10	10
EPS	59.1	47.8	48.13
Debt	5.05	6.72	4.19
Net-Worth	13.91	12.02	10.48

(i) During the financial year 2018-19, the Company recorded revenue from operations of Rs. 53.04 Crores, PBT of Rs. 2.60 Crores and Net Profit of Rs. 1.89 Crores as against that of Rs. 51.83 Crores, Rs. 2.28 Crores and Rs. 1.53 Crores respectively in the previous financial year 2017-18.

(ii) The net profit of the Company during the financial year 2018-19 is nearly same as it was during the last financial year although there is growth in the revenue , due to the similar increase in the expenses the Company was unable to maintain its growth in the Net Profits of the Company.

HICKS Thermometer Annual Report 2019-20

HICKS Thermometer Annual Report 2018-19
HICKS Thermometer Annual Report 2017-18
HICKS Thermometer Annual Report 2016-17

HICKS Thermometer Annual Report 2015-16

Company Address A 12-13INDUSTRIAL ESTATE ALIGARH, UTTAR PRADESH UTTAR PRADESH, INDIA -202001 Registrar: Skyline Financial Services Private Limited D-153 A, Ist Floor, Okhla Industrial Area, Phase I, New Delhi – 110020 Tel: + 91 11 64732681 -88 Fax: + 91 1126812682 Email: info@skylinerta.com Website: www.skylinerta.com

About HICKS THERMOMETERS (INDIA) LIMITED Unlisted Shares

Established on 02 June 1961 Hicks Thermometers India Limited is registered at the Registrar of Companies, Kanpur. The authorized share capital of the company is Rs. 50,00,000 and its paid-up capital is Rs. 32,55,000. Hicks Thermometers India Ltd. manufactures and distributes a wide range of medical and healthcare products. The product line includes automatic blood pressure monitors, automatic digital blood pressure monitors, automatic blood pressure monitors, automatic digital blood pressure monitors, thermometers, medical digital thermometers, diagnostic tools & equipment, disposable medical products, and many other health care products. HICKS works with a wide range of pharmaceutical products in addition to healthcare products.

list of the major products of Hicks Thermometers India Ltd. –

Thermometers: Glass Thermometer, Digital Thermometer

Digital B.P. Monitor,

Nebulizer,

Pulse Oximeter,

Home care range:- Hot Water Bottle, Electric Heating Belt, Hot & Cold Pad, etc.

Diagnostics Products: Pregnancy Test Kit, Malaria Test Kit, HIV Test Kit, etc.

Rehabilitation Range: Cervical Collar, L. S. Belt, Abdominal Belt, Knee Cap, etc.

Incontinence Range: Adult diapers, Underpad,

Medical Disposables: Infusion Set, Face Mask

Hospital Range

The equity shares of the Company were listed on the UP Stock Exchange (“UPSE”) and the Calcutta Stock Exchange Limited (“CSE”). UPSE has become a derecognized stock exchange. The Company has been placed on the Dissemination Board (“DB”) of the National Stock Exchange Limited (“NSE”/ “Stock Exchange”) as referred by CSE vide SEBI letter Ref No SEBI/HO/MRD/DSA/OW/P/34060/1 dated 12th December 2018.

INCORPORATION DETAILS

CIN	U33112UP1961PLC002846
Registration Date	2nd June 1961
Company Name	Hicks Thermometers India Limited
Email Address	hicksindia@gmail.com
Category/Sub-category of the Company	Public Company / Limited by Shares
Registration Number	2846
Address of the Registered office & contact details	A-12 &13 Industrial Estate, Aligarh-202001 (UP) Email: hicksindia@gmail.com
Company Secretary & Compliance Officer	Mrs. Sumati Tandon
Name, Address & contact details of the Registrar & Transfer Agent, if any	Skyline Financial Services Private Limited D-153 A, Ist Floor, Okhla Industrial Area, Phase I, New Delhi – 110020 Tel: + 91 11 64732681 -88

BOARD OF DIRECTORS

S.NO.	Name of the Directors	Category
1.	Mr. Hari Prakash Gupta	Managing Director
2.	Mr. Siddharth Gupta	Managing Director
3.	Mr. Sher Singh	Director
4.	Dr. (Miss) Ranjana Bansal	Director
5.	Mr. Bharat Bhusan Deva	Director
6.	Mrs. Kusum Gupta	Director
7.	Mr. Bharat Bansal	Director

Principal Business Activities of the Company

Name & Description of main products/services	NIC Code of the Product /service	% to the total turnover of the company
Wholesale of Scientific, Medical, and Surgical Machinery and Equipment	46596	100%

SHAREHOLDING PATTERN (As of 31-03-2019)

S. No.	Shareholder’s Category	No. of Shares	% of total Shares of the company
1.	Promoters	2,20,050	79.87%
2.	Public	55,450	20.13%
	Total	2,75,500	100%

INDUSTRY OUTLOOK

Medical equipment like thermometers, monitoring devices, disposable masks, and gloves are in higher demand because of the COVID-19 pandemic.

The operating Profits of the company have been increasing with a CAGR of 21.5% from 2017 to 2020. Healthcare has become one of India’s largest sectors,

both in terms of revenue and employment. The healthcare market is expected to increase three-fold to Rs. 8600000 Cr. by FY 2022.

Hicks Thermometers India Limited Balance Sheet (Rs in lakhs)

Particulars	31-03-2023	31-03-2022
EQUITY AND LIABILITIES
Shareholder’s funds
Share capital	32.55	32.55
Reserves and surplus	3,174.98	2,963.56
Money received against share warrants	3,207.53	2,996.11
Non-current liabilities
Long-term borrowings	448.05	406.41
Deferred tax liabilities (Net)	5.96	5.61
Other long term liabilities
Long-term provisions	454.02	412.02
Current liabilities
Micro enterprises and small enterprises	258.4	650.36
Others
Other current liabilities	86.44	49.23
Short-term provisions	6.54	7.29
TOTAL	4,012.92	4,115.01
ASSETS
Non-current assets
Property, Plant and Equipment	263.09	230.45
Non-current investments	246.6	150.1
Long-term loans and advances	66.98	66.43
Other non-current assets	576.66	446.97
Current assets
Inventories	925.44	1,187.12
Trade receivables	716.05	681.33
Cash and cash equivalents	1,759.37	1,601.34
Other current assets	35.4	198.24
TOTAL	4,012.92	4,115.01

Hicks Thermometers India Limited Profit & Loss Statement (Rs in lakhs)

Particulars	31-03-2023	31-03-2022
Revenue
Revenue from operations	4,522.61	9,149.75
Less: Excise duty
Net Sales	4,522.61	9,149.75
Other income	80.64	69.7
Total Income	4,603.25	9,219.45
Expenses
Cost of material Consumed	137.09	334.17
Purchase of stock-in-trade	2,070.92	3,800.45
Changes in inventories	192.09	302.3
Employee benefit expenses	530.58	611.58
Finance costs	41.72	43.84
Depreciation and amortization expenses	36.17	32.08
Other expenses	1,269.03	3,060.18
Gain(Loss) on foreign currency transaction	37.53	55.61
Total expenses	4,315.14	8,240.21
Profit before exceptional, extraordinary, and prior period items and tax	288.11	979.24
Profit before extraordinary and prior period items and tax	288.11	979.24
Profit before tax	288.11	979.24
Tax expenses
Current tax	76.34	246.26
Deferred tax	0.35	-0.51
Profit(Loss) for the period	211.42	733.49
Earnings per share-in Basic
Before extraordinary Items	76.74	266.24
After extraordinary Adjustment	76.74	266.24

Hicks Thermometers India Limited Consolidated Cash Flow Statement (Rs in lakhs)

Particulars	31-03-2023	31-03-2022
Cash Flow From Operating Activities
Net Profit before tax and extraordinary items	288.11	979.24
Depreciation & Amortization Expenses	36.17	32.08
Finance Cost	79.25	99.45
Interest received	-78.44	-69.7
Operating profits before Working Capital Changes	325.09	1,041.06
(Increase) / Decrease in trade receivables	-34.71	-61.86
Increase / (Decrease) in trade payables	-391.95	72.49
(Increase) / Decrease in inventories	261.68	199.73
Increase / (Decrease) in other current liabilities	36.45	8.35
(Increase) / Decrease in other current assets	162.85	-140.67
Cash generated from Operations	359.4	1,119.10
Net Cash flow from Operating Activities(A)	359.4	1,119.10
Cash Flow From Investing Activities
Purchase of tangible assets	-68.81	-95.8
Proceeds from sales of tangible assets	0.39
Non Current Investments / (Purchased) sold	-96.5	-150
Interest Received	78.44	69.7
Cash advances and loans made to other parties	-0.55
Cash advances and loans received back	0.97
Net Cash used in Investing Activities(B)	-87.42	-174.74
Cash Flow From Financing Activities
Finance Cost	-79.25	-99.45
Increase in / (Repayment) of Short term Borrowings		-44.51
Increase in / (Repayment) of Long term borrowings	41.64	22.15
Other Inflows / (Outflows) of cash	-76.34	-246.26
Net Cash used in Financing Activities(C)	-113.95	-368.07
Net Increase / (Decrease) in Cash & Cash Equivalents	158.03	576.29
Cash & Cash Equivalents at Beginning of period	1,601.34	1,025.06
Cash & Cash Equivalents at End of period	1,759.37	1,601.34
Net Increase / (Decrease) in Cash & Cash Equivalents	158.03	576.29

Here is the analysis of cash flow statement of 2023 and 2022:

Cash Flow from Operating Activities (CFO):

CFO for 2023: 359.4

CFO for 2022: 1,119.10

Cash generated from operating activities decreased significantly from 1,119.10 in 2022 to 359.4 in 2023. This decline could be attributed to various factors such as a decrease in operating profits, changes in working capital, or other operational adjustments.

Cash Flow from Investing Activities (CFI):

CFI for 2023: -87.42

CFI for 2022: -174.74

Cash used in investing activities decreased from -174.74 in 2022 to -87.42 in 2023. This could indicate a reduction in investments in tangible assets and non-current investments, which may be a strategic decision to conserve cash or focus on other areas of the business.

Cash Flow from Financing Activities (CFF):

CFF for 2023: -113.95

CFF for 2022: -368.07

Cash used in financing activities decreased from -368.07 in 2022 to -113.95 in 2023. This decrease could be due to reduced repayment of borrowings and other outflows of cash related to financing activities.

Net Increase/(Decrease) in Cash & Cash Equivalents:

For 2023: 158.03 (Increase)

For 2022: 576.29 (Increase)

The net increase in cash and cash equivalents decreased from 576.29 in 2022 to 158.03 in 2023. This indicates that the company had a lower surplus of cash generated from its operating, investing, and financing activities in 2023 compared to 2022.

Financial Ratios of Hicks Thermometers India Limited

Ratios	31-03-2023	31-03-2022
Current Ratio	9.78	5.19
Debt-Equity Ratio	0.14	0.14
Debt Service Coverage Ratio	0	–
Return on Equity Ratio	0.07	0.28
Inventory turnover ratio	4.28	7.11
Trade Receivables turnover ratio	6.47	14.07
Trade payables turnover ratio	4.86	6.73
Net capital turnover ratio	1.47	3.09
Net profit ratio	0.05	0.08
Return on Capital employed	0.09	0.3

Here is the summary of financial and operational metrics for Hicks Thermometers India Limited for year 2023 & 2022:

Current Ratio: This ratio measures a company’s ability to pay its short-term obligations with its short-term assets. A higher ratio indicates better liquidity. In this case, the current ratio has significantly increased from 5.19 in 2022 to 9.78 in 2023, suggesting a considerable improvement in the company’s liquidity position.

Debt-Equity Ratio: This ratio indicates the proportion of debt and equity used to finance the company’s assets. A lower ratio is generally favorable as it implies lower financial risk. The ratio has remained stable at 0.14 in both 2022 and 2023, indicating a consistent capital structure.

Debt Service Coverage Ratio: This ratio measures a company’s ability to cover its debt obligations with its operating income. A ratio of 0 suggests that the company’s operating income is insufficient to cover its debt obligations. It’s important to investigate why this ratio is 0 in 2023, as it could indicate potential financial strain.

Return on Equity (ROE) Ratio: ROE measures a company’s profitability relative to shareholders’ equity. A higher ratio indicates better profitability. The ROE has decreased from 0.28 in 2022 to 0.07 in 2023, suggesting a decline in profitability relative to equity.

Inventory Turnover Ratio: This ratio measures how efficiently a company manages its inventory. A higher ratio indicates better inventory management. The decrease in the inventory turnover ratio from 7.11 in 2022 to 4.28 in 2023 suggests a slowdown in inventory turnover, which could indicate issues with sales or production.

Trade Receivables Turnover Ratio: This ratio measures how efficiently a company collects cash from its credit sales. A higher ratio indicates better receivables management. The decrease in the ratio from 14.07 in 2022 to 6.47 in 2023 suggests a significant slowdown in the collection of receivables, which could impact cash flow.

Trade Payables Turnover Ratio: This ratio measures how efficiently a company pays its suppliers. A higher ratio indicates better payable management. The decrease in the ratio from 6.73 in 2022 to 4.86 in 2023 suggests a slowdown in the payment of trade payables, which could affect supplier relationships.

Net Capital Turnover Ratio: This ratio measures how efficiently a company generates revenue relative to its capital employed. A higher ratio indicates better utilization of capital. The decrease in the ratio from 3.09 in 2022 to 1.47 in 2023 suggests a decline in revenue generation efficiency.

Net Profit Ratio: This ratio measures the percentage of net profit relative to revenue. A higher ratio indicates better profitability. The decrease in the net profit ratio from 0.08 in 2022 to 0.05 in 2023 suggests a decline in profitability.

Return on Capital Employed (ROCE): ROCE measures the efficiency and profitability of a company’s capital investments. A higher ratio indicates better utilization of capital. The decrease in ROCE from 0.30 in 2022 to 0.09 in 2023 indicates a decline in the efficiency of capital utilization.

Industry Overview

Hicks Thermometers India Limited comes under the Healthcare sector. The healthcare industry comprises diverse sectors dedicated to maintaining and improving human health. Healthcare services encompass hospitals, clinics, and diagnostic centers, providing a spectrum of medical care. Pharmaceutical companies develop and market drugs, alongside biotechnology firms pioneering innovative therapies. Medical devices and equipment manufacturers produce tools vital for diagnosis and treatment. Healthtech companies innovate digital solutions, including telemedicine and health information systems. Health insurance and managed care organizations offer financial protection and healthcare management. Facilities management ensures safe and efficient healthcare environments. Education and training institutions prepare healthcare professionals, while regulatory bodies uphold safety and quality standards. Overall, the healthcare industry is dynamic, evolving to meet emerging health needs, technological advancements, and regulatory demands.

Blog